CNBCLean R·
U.S. FDA approves first mRNA flu shot from Moderna
The shot, mFlusiva, was given a traditional approval for adults aged 50 to 64, and an accelerated approval for those 65 years and older.
Read at CNBC →
Business · 1 sources covering this
U.S. FDA approves first mRNA flu shot from Moderna
The shot, mFlusiva, was given a traditional approval for adults aged 50 to 64, and an accelerated approval for those 65 years and older.
Coverage spectrum
0 L · 0 C · 1 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/c5a6e5660dc26dcf412cb89f36ca95621f0a8554" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="U.S. FDA approves first mRNA flu shot from Moderna"></iframe>
